Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Elixxer Ltd. V.QBA


Primary Symbol: V.ELXR

Elixxer Ltd is a Canada based company engaged in growing and producing medical-grade cannabis. It focuses on making investments in Nutraceuticals, Cosmetics, Pharma, and Cultivation and Extraction sectors.


TSXV:ELXR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by keeniinvestoron Mar 26, 2019 5:53pm
276 Views
Post# 29539441

Facts speak volumes ...

Facts speak volumes ...In Sproutly's nov 30/18 (q3) financials, released jan 28/19, they mention the LOI with GCL.  However, in LGC's dec 31/18 (q1/19) financials, released mch 12/19, there is not one word regarding the LOI with Sproutly.  I'm very interested to see what Sproutly's feb 28/19 (AFS) report states about the status of LOI.
  • Nov 13/18 NR (do the math) - "The signing of the definitive agreement and establishment of the joint venture is expected to occur in January, 2019"

AND ALSO .......

Sep 20/18 NR (TSX approved) – “$2.5-million secured debenture, convertible into an initial 30-per-cent strategic interest in GCL … 5-per-cent royalty on GCL's net sales for $2-million, payable by way of 15,854,141 shares of LGC. The transaction is now fully completed  ......................................................................................................................... $4,500,000 *
*remember how they bumped royalty up to $2.4M in apr/18 then in may  reduced it back to $2M?)
  • Sep 30/18 financials - "$2,500,000 secured debenture ...acquired a 5% royalty on GCL's net sales for an unlimited time period for $3,091,558" .............................................................................................................. $5,591,558
  • Dec 31/18 financials - "as at Dec 31, 2018, the GCL Debenture was fully drawn down with total consideration paid amounting to $5,591,558 (September 30, 2018 - $5,591,558)
  • $1,091,558 difference ????? (not what TSX approved)
Jun 21/18 (9 mths ago) – “GCL is also commencing the expansion of its current growing facility in Montego Bay and is in late-stage negations for the acquisition of an additional 300 acres of land in Jamaica. “

PER WEBSITE (Q1/19):
  • supply agreement with Germany finalized
  • Zimmer & co rapid expansion into Caribbean pharmacies and central & south America.
  • is Zimmer 25% ($1M loan) or 6.75% ($270k usd) ?????
 

<< Previous
Bullboard Posts
Next >>